||Marcel Mérieux creates the Institut Mérieux, which developed a large range of vaccines and biological products, including reagents. Alain Mérieux was president of the Institut for 25 years, until 1994.
|Creation of BD Mérieux equally owned by Institut Mérieux and Becton Dickinson.
||Alain Mérieux takes majority control of the company: BD Mérieux becomes bioMérieux.
||API Systems (France) acquisition.
||Vitek acquisition from McDonnel Douglas (U.S.).
||Organon Teknika Diagnostic acquisition from Akzo Nobel (Netherlands).
||Listing of bioMérieux on the stock exchange.
||Inauguration of the Christophe Mérieux Center, dedicated to molecular biology and microsystems research (Grenoble, France).
Bacterial Barcodes (U.S.) acquisition - DiversiLab™.
||Biomedics (Spain) acquisition.
BTF (Australia) acquisition.
||Joint venture with Sysmex (Japan).
Joint venture with Shanghai Kehua Bio-engineering (China).
AB BIODISK (Sweden) acquisition.
AviaraDx (U.S.) acquisition - renamed bioTheranostics, Inc.
||Strategic partnership with the French Atomic Energy Commission (CEA).
||Acquisition of Meikang Biotech (China).
Acquisition of Shanghai Zenka Biotechnology (China).
||Acquisition of AES Laboratoire (France)
Acquisition of ARGENE (France)